Cambria Pharmaceuticals is focused on discovering innovative treatments for serious and progressively disabling neurological disorders. The company exploits recent discoveries in the genetic basis of these disorders to engineer novel disease models and identify first-in-class disease-modifying compounds. Cambria leverages collaborative relationships with academic institutions and patient-focused foundations to advance its programs in ALS (Lou Gehrig's disease) and other serious neurological diseases.
Company Details
- Address
- Medford, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- cambriapharma.com
- HQ
- Medford
Cambria Biosciences Questions
Cambria Biosciences's website is cambriapharma.com
Cambria Biosciences's LinkedIn profile is https://www.linkedin.com/company/cambria-biosciences
Cambria Biosciences's industry is
Biotechnology Research
Cambria Biosciences's top competitors are
Neuroset,
Eragen Biosciences,
Helicos Biosciences Corporation,
Nimbus Therapeutics,
Extera Partners Llc,
Cambrian Bio,
Jsb-Partners, Lp,
Exact Sciences,
Vertex Pharmaceuticals,
Activx Biosciences.
Cambria Biosciences's categories are Biotechnology Research
